{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:51:55Z","timestamp":1770893515503,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","award":["SKLNMZZ202201"],"award-info":[{"award-number":["SKLNMZZ202201"]}],"id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0902000"],"award-info":[{"award-number":["2018YFA0902000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","award":["CPU2022QZ014"],"award-info":[{"award-number":["CPU2022QZ014"]}],"id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX09201002-001\u2013001"],"award-info":[{"award-number":["2018ZX09201002-001\u2013001"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.intimp.2023.111261","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T13:45:36Z","timestamp":1700574336000},"page":"111261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The combination of tetracyclines effectively ameliorates liver fibrosis via inhibition of EphB1\/2"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6727-975X","authenticated-orcid":false,"given":"Yueqing","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoxin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3869-2463","authenticated-orcid":false,"given":"Shuzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2023.111261_b0005","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1016\/j.cub.2017.01.003","article-title":"Ephs and ephrins","volume":"27","author":"Taylor","year":"2017","journal-title":"Curr. Biol."},{"issue":"39","key":"10.1016\/j.intimp.2023.111261_b0010","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1038\/s41388-019-0931-2","article-title":"Eph receptor signalling: from catalytic to non-catalytic functions","volume":"38","author":"Liang","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.intimp.2023.111261_b0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrm.2015.16","article-title":"Mechanisms of ephrin-Eph signalling in development, physiology and disease","volume":"17","author":"Kania","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111261_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11926-019-0825-x","article-title":"Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis","volume":"21","author":"Wu","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2023.111261_b0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12079-023-00750-1","article-title":"Ephrin-Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies","volume":"17","author":"Mekala","year":"2023","journal-title":"J. Cell Commun. Signal."},{"issue":"13","key":"10.1016\/j.intimp.2023.111261_b0030","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.3390\/cancers15133434","article-title":"Unraveling the significance of EPH\/Ephrin signaling in liver cancer: Insights into tumor progression and therapeutic implications","volume":"15","author":"Papadakos","year":"2023","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.intimp.2023.111261_b0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2023.111261_b0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2023.111261_b0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111261_b0050","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/hep.27868","article-title":"Erythropoietin-producing hepatocellular receptor B2 receptor tyrosine kinase: A novel regulator of infection- and inflammation-induced liver fibrosis","volume":"62","author":"Butler","year":"2015","journal-title":"Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111261_b0055","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.27792","article-title":"The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice","volume":"62","author":"Mimche","year":"2015","journal-title":"Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111261_b0060","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/s41598-018-20926-9","article-title":"EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells","volume":"8","author":"Mimche","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2023.111261_b0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41419-020-2613-y","article-title":"Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.intimp.2023.111261_b0070","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.3390\/ijms24043415","article-title":"Neddylation of EphB1 regulates its activity and associates with liver fibrosis","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"682","key":"10.1016\/j.intimp.2023.111261_b0075","doi-asserted-by":"crossref","first-page":"eadc9653","DOI":"10.1126\/scitranslmed.adc9653","article-title":"Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis","volume":"15","author":"Xiao","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.intimp.2023.111261_b0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","article-title":"Kinase drug discovery 20 years after imatinib: progress and future directions","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.intimp.2023.111261_b0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrd4175","article-title":"Therapeutic targeting of EPH receptors and their ligands","volume":"13","author":"Boyd","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2023.111261_b0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-pharmtox-011112-140226","article-title":"Eph receptors and ephrins: therapeutic opportunities","volume":"55","author":"Barquilla","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.intimp.2023.111261_b0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016265118","article-title":"Identification of tetracycline combinations as EphB1 tyrosine kinase inhibitors for treatment of neuropathic pain","volume":"118","author":"Ahmed","year":"2021","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.intimp.2023.111261_b0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"2","key":"10.1016\/j.intimp.2023.111261_b0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.onc.1203304","article-title":"Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses","volume":"19","author":"Zisch","year":"2000","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.intimp.2023.111261_b0110","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1128\/MCB.20.13.4791-4805.2000","article-title":"Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors","volume":"20","author":"Binns","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2023.111261_b0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-010715-103715","article-title":"The cellular thermal shift assay: A novel biophysical assay for in situ drug target engagement and mechanistic biomarker studies","volume":"56","author":"Martinez Molina","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2023.111261_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110579","article-title":"Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers","volume":"104","author":"Lau","year":"2023","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.intimp.2023.111261_b0125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: Unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2023.111261_b0130","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.3390\/ijms24119671","article-title":"Liver fibrosis resolution: From Molecular mechanisms to therapeutic opportunities","volume":"24","author":"Pei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.111261_b0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcdb.2011.10.018","article-title":"Eph\/ephrin signaling: genetic, phosphoproteomic, and transcriptomic approaches","volume":"23","author":"Bush","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2023.111261_b0140","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fphar.2015.00300","article-title":"New insight into the anti-liver fibrosis effect of multitargeted tyrosine kinase inhibitors: From molecular target to clinical trials","volume":"6","author":"Qu","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111261_b0145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"issue":"12","key":"10.1016\/j.intimp.2023.111261_b0150","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/pharmaceutics13122085","article-title":"The development of third-generation tetracycline antibiotics and new perspectives","volume":"13","author":"Rusu","year":"2021","journal-title":"Pharmaceutics."},{"issue":"5","key":"10.1016\/j.intimp.2023.111261_b0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/13543784.2022.2054325","article-title":"Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications","volume":"31","author":"Garrido-Mesa","year":"2022","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.intimp.2023.111261_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175949","article-title":"Tetracycline antibiotics: Potential anticancer drugs","volume":"956","author":"Li","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111261_b0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111261_b0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10787-011-0077-5","article-title":"Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study","volume":"19","author":"Leite","year":"2011","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2023.111261_b0175","doi-asserted-by":"crossref","first-page":"1160053","DOI":"10.3389\/fmed.2023.1160053","article-title":"An update on animal models of liver fibrosis","volume":"10","author":"Wu","year":"2023","journal-title":"Front. Med."},{"issue":"8","key":"10.1016\/j.intimp.2023.111261_b0180","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s10646-020-02319-9","article-title":"Recovery of gut microbiota in mice exposed to tetracycline hydrochloride and their correlation with host metabolism","volume":"30","author":"Zhao","year":"2021","journal-title":"Ecotoxicology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923015886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923015886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:14:54Z","timestamp":1761588894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923015886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":36,"alternative-id":["S1567576923015886"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111261","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination of tetracyclines effectively ameliorates liver fibrosis via inhibition of EphB1\/2","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111261"}}